News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,872 Results
Type
Article (77448)
Company Profile (342)
Press Release (777062)
Multimedia
Podcasts (279)
Webinars (42)
Section
Business (258707)
Career Advice (3848)
Deals (38870)
Drug Delivery (235)
Drug Development (88916)
Employer Resources (212)
FDA (18504)
Job Trends (17109)
News (385771)
Policy (38600)
Tag
2025 Best Places to Work (2)
2026 Best Places to Work (3)
2027 BioCapital Elite (1)
2027 BioCapital Standard (5)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (3)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (11)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (8)
2027 Genetown Elite (6)
2027 Genetown Premier (1)
2027 Genetown Standard (12)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (12)
40 Under 40 (2)
Academia (3104)
Academic (2)
Accelerated approval (74)
ADA (53)
Adcomms (44)
Allergies (231)
Alliances (55802)
ALS (284)
Alzheimer's disease (2117)
Antibody-drug conjugate (ADC) (753)
Approvals (19081)
Artificial intelligence (1066)
ASCO (349)
Autoimmune disease (499)
Automation (83)
Bankruptcy (392)
Belgium (36)
Best Places to Work (12621)
BIO (79)
Biologics (88)
BIOSECURE Act (23)
Biosimilars (302)
BioSpace Insights (265)
Biotechnology (239)
Bispecific (45)
Bladder cancer (242)
Brain cancer (99)
Breast cancer (956)
Cancer (7821)
Cardiovascular disease (660)
Career advice (3335)
Career pathing (65)
CAR-T (451)
CDC (82)
CDMO (222)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1219)
Cervical cancer (66)
Clinical research (78391)
Collaboration (2827)
Commercialization (58)
Company closure (10)
Compensation (1875)
Complete response letters (126)
COVID-19 (3073)
CRISPR (147)
CRO (4)
C-suite (1679)
Cystic fibrosis (182)
Data (10644)
Decentralized trials (4)
Denatured (110)
Depression (223)
Dermatology (189)
Diabetes (831)
Diagnostics (7899)
Digital health (82)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (523)
Drug pricing (252)
Drug shortages (40)
Duchenne muscular dystrophy (380)
Earnings (99895)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (432)
Events (137418)
Executive appointments (1373)
Eye disease (17)
FDA (23490)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (42)
Funding (2319)
Gene editing (313)
Generative AI (100)
Gene therapy (962)
GLP-1 (1386)
Government (5583)
Grass and pollen (8)
Guidances (439)
Healthcare (21408)
Hematology (204)
HIV (119)
Huntington's disease (88)
Idiopathic pulmonary fibrosis (15)
IgA nephropathy (154)
Immunology and inflammation (425)
Immuno-oncology (159)
Indications (287)
Infectious disease (3524)
Inflammatory bowel disease (279)
Inflation Reduction Act (17)
Influenza (164)
Intellectual property (377)
Interviews (752)
IPO (17815)
IRA (61)
Job creations (4770)
Job search strategy (2661)
JPM (73)
Kidney cancer (30)
Kidney disease (171)
Labor market (148)
Layoffs (724)
Leadership (69)
Legal (9645)
Licensing (99)
Liver cancer (119)
Longevity (56)
Lung cancer (1084)
Lung diease (22)
Lymphoma (545)
Machine learning (77)
Management (72)
Manufacturing (1602)
Marketing (33)
MASH (249)
Medical affairs (5)
Medical device (15421)
Medtech (15737)
Mergers & acquisitions (22590)
Metabolic disorders (2097)
mRNA (333)
Multiple sclerosis (254)
Multispecific (6)
NASH (24)
Netherlands (32)
Neurodegenerative disease (620)
Neuropsychiatric disorders (150)
Neuroscience (4259)
Neurotech (3)
NextGen: Class of 2026 (7593)
Non-profit (5173)
Now hiring (99)
Obesity (991)
Opinion (406)
Ovarian cancer (295)
Pain (346)
Pancreatic cancer (448)
Parkinson's disease (484)
Partnered (49)
Patents (792)
Patient advocacy (6)
Patient recruitment (984)
Patient selection (97)
Peanut (77)
People (67515)
Peptides (30)
Pharmaceutical (66)
Pharmacy benefit managers (42)
Phase 1 (24289)
Phase 2 (34129)
Phase 3 (25882)
Pipeline (13778)
Policy (426)
Postmarket research (3152)
Preclinical (10613)
Press Release (74)
Prostate cancer (405)
Psychedelics (96)
Radioligand (3)
Radiopharmaceuticals (440)
Rare diseases (1575)
Real estate (7109)
Recruiting (84)
Regenerative medicine (28)
Regulatory (30884)
Reports (94)
Research institute (2807)
Resumes & cover letters (609)
Rett syndrome (59)
RNA editing (39)
RSV (105)
Schizophrenia (224)
Series A (402)
Series B (278)
Service/supplier (15)
Sickle cell disease (142)
Special edition (36)
Spinal muscular atrophy (199)
Sponsored (61)
Startups (4212)
State (2)
Stem cells (6)
Stomach cancer (24)
Substance use disorders (22)
Supply chain (170)
Switzerland (9)
Tariffs (107)
Tax incentives (2)
The Weekly (166)
Vaccines (1423)
Venture capital (176)
Weight loss (662)
Wet AMD (7)
Women's health (188)
Women in leadership (1)
Worklife (28)
Date
Last 7 days (844)
Last 30 days (2967)
Last 365 days (33379)
2026 (28059)
2025 (32416)
2024 (37480)
2023 (42549)
2022 (53909)
2021 (58694)
2020 (57637)
2019 (51287)
2018 (39072)
2017 (36723)
2016 (37397)
2015 (44112)
2014 (39287)
2013 (35116)
2012 (35481)
2011 (35427)
2010 (33750)
Location
Africa (1208)
Alabama (116)
Alaska (7)
Arizona (461)
Arkansas (17)
Asia (50836)
Australia (8704)
California (16751)
Canada (4620)
China (2001)
Colorado (739)
Connecticut (747)
Delaware (530)
Europe (116115)
Florida (2555)
Georgia (551)
Hawaii (5)
Idaho (70)
Illinois (1451)
India (148)
Indiana (771)
Iowa (35)
Japan (760)
Kansas (157)
Kentucky (67)
Louisiana (68)
Maine (97)
Maryland (1983)
Massachusetts (12092)
Michigan (460)
Minnesota (918)
Mississippi (8)
Missouri (185)
Montana (37)
Nebraska (31)
Nevada (193)
New Hampshire (93)
New Jersey (4423)
New Mexico (38)
New York (4383)
North Carolina (2186)
North Dakota (13)
Northern California (8556)
Ohio (527)
Oklahoma (32)
Oregon (53)
Pennsylvania (3200)
Puerto Rico (37)
Rhode Island (62)
South America (1587)
South Carolina (104)
South Dakota (2)
Southern California (6684)
Tennessee (278)
Texas (2773)
United States (59447)
Utah (514)
Vermont (2)
Virginia (431)
Washington D.C. (89)
Washington State (1349)
West Virginia (4)
Wisconsin (196)
Wyoming (6)
854,872 Results for "heidrick and struggles".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
Verastem reports ‘robust’ response rate in pancreatic cancer subgroup where Rasonque struggled
Revolution Medicines’ recently approved drug showed a 24% overall response rate and a high rate of side effects in patients whose cancer has a G12D mutation, reinforcing Mizuho’s view that a more specific agent such as Verastem Oncology’s VS-7375 “should come first for G12D patients.”
October 14, 2026
·
3 min read
·
Heather McKenzie
Schizophrenia
As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door
Despite the recent emergence of a new drug class, schizophrenia remains one of the most challenging neuropsychiatric diseases to treat—and Cobenfy’s first steps into the market indicate there is still room to grow.
August 10, 2026
·
6 min read
·
Michael Gibney
Press Releases
ACTG Announces Behavioral Health and Implementation Study to Optimize Long-Acting HIV Treatment among People who have Struggled to Maintain HIV Suppression
July 19, 2026
·
4 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
FDA
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
Summit Therapeutics scores a $2 billion equity investment from AstraZeneca to support ivonescimab’s late-stage development; uniQure crashes after four-year data from its Huntington’s disease gene therapy failed to impress; Kyverna Therapeutics brings new light to a struggling CAR T space in autoimmune disease.
September 30, 2026
·
1 min read
·
Jef Akst
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
Despite ranking among the world’s top scientific producers, Italy has struggled to turn research into startups. Now, stronger tech transfer offices, private capital and returning scientists are pushing the country toward a more mature innovation economy.
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Psychedelics
Psychedelics on the cusp of market breakthrough as clinical, policy support grow
While there are several FDA-approved psychiatric medicines on the market, many patients still struggle to achieve lasting symptom relief. Psychedelics could help fill this gap.
August 10, 2026
·
8 min read
·
Tristan Manalac
Manufacturing
As CGT Struggles To Scale, FDA’s New Designation Could Smooth Post-Approval Pivots
Experts suggest the FDA’s Advanced Manufacturing Technologies designation could be a lifeline for improving production processes for approved cell and gene therapies.
November 25, 2025
·
4 min read
·
Nick Paul Taylor
Earnings
BMS Beats Again Despite Eliquis and Cobenfy Disappointments
Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake.
February 5, 2026
·
2 min read
·
Dan Samorodnitsky
Government
FDA Struggles To Keep Lights On Amid Shutdown as Biopharmas Begin To See Delays
While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in dealings with the agency, while insiders warn of falling morale and a negative perception from the rest of the biopharma world.
October 29, 2025
·
4 min read
·
Dan Samorodnitsky
1 of 85,488
Next
